Link opens in a new tab
opens in new window
Michiel is a leader in Deloitte's Life Sciences M&A practice. He advises clients on growth strategy and M&A topics across the deal life cycle, focused on complex, gobal acquisitions and divestitures.
Michiel is an expert and thoughtleader across growth strategy, M&A and strategic alliances topics. He has more than 10 years of experience in helping his clients pursue inorganic growth opportunities by defining M&A strategies, executing operational & commercial diligence, and managing integrations & divestiture execution. He plays at the intersection of pharmaceuticals, med tech, and technology with deals ranging from $100M-$40B in size. He is a published scientist with a Master's in Chemistry from the University of Bath.
Market: Deloitte United States